Stock DNA
Pharmaceuticals & Biotechnology
CNY 6,853 Million (Mid Cap)
50.00
NA
0.00%
-0.68
6.54%
2.59
Revenue and Profits:
Net Sales:
226 Million
(Quarterly Results - Sep 2025)
Net Profit:
48 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.78%
0%
-14.78%
6 Months
3.44%
0%
3.44%
1 Year
37.13%
0%
37.13%
2 Years
-18.39%
0%
-18.39%
3 Years
-50.18%
0%
-50.18%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
ACROBiosystems Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
22.73%
EBIT Growth (5y)
-14.95%
EBIT to Interest (avg)
48.47
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.66
Sales to Capital Employed (avg)
0.23
Tax Ratio
4.17%
Dividend Payout Ratio
48.37%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.75%
ROE (avg)
6.17%
Valuation key factors
Factor
Value
P/E Ratio
50
Industry P/E
Price to Book Value
2.88
EV to EBIT
65.92
EV to EBITDA
33.45
EV to Capital Employed
6.71
EV to Sales
7.92
PEG Ratio
1.60
Dividend Yield
NA
ROCE (Latest)
10.19%
ROE (Latest)
5.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
225.60
164.10
37.48%
Operating Profit (PBDIT) excl Other Income
38.00
30.40
25.00%
Interest
0.00
0.60
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
48.30
25.30
90.91%
Operating Profit Margin (Excl OI)
168.40%
62.50%
10.59%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 37.48% vs 13.80% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 90.91% vs -24.25% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
644.10
543.00
18.62%
Operating Profit (PBDIT) excl Other Income
131.00
136.90
-4.31%
Interest
5.70
4.50
26.67%
Exceptional Items
-0.00
0.70
-100.00%
Consolidate Net Profit
120.00
147.60
-18.70%
Operating Profit Margin (Excl OI)
91.20%
142.60%
-5.14%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 18.62% vs 14.61% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -18.70% vs -25.90% in Dec 2023
About ACROBiosystems Co., Ltd. 
ACROBiosystems Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






